Clinical Trial Update: A Study of ATRA in the Treatment of ITP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on all-trans retinoic acid (ATRA) for immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• ATRA (all-trans retinoic acid)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN